[Is it possible to reduce the cost of clinical research of new drugs? Cooperation between the pharmaceutical industry and health care authorities].
Dal-Ré
R
R
Departamento Médico. Glaxo SmithKline, PTM. Madrid.
D003365:Costs and Cost Analysis; D017277:Drug Approval; D004345:Drug Industry / Q000191:economics*; D006296:Health Services / Q000191:economics*; D011634:Public Health; D012106:Research / Q000191:economics*; D012307:Risk Factors; D014481:United States